Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV vaccines
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV vaccines, covering 2022-04-25 to 2022-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults [Phase 1]